• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过心血管磁共振评估小儿慢性肾脏病中的心脏重塑

Evaluation of cardiac remodeling in pediatric chronic kidney disease by cardiovascular magnetic resonance.

作者信息

Song Sisi, Xie Linjun, Xu Huayan, Xu Ke, Fu Hang, Zhang Lu, Hou Ruilai, Tao Yuhong, Guo Yingkun

机构信息

Department of Radiology, West China Second University Hospital, Sichuan University, Chengdu, China.

Key Laboratory of Birth Defects and Related Diseases of Women and Children, (Sichuan University), Ministry of Education, Chengdu, China.

出版信息

BMC Cardiovasc Disord. 2024 Oct 1;24(1):526. doi: 10.1186/s12872-024-04179-1.

DOI:10.1186/s12872-024-04179-1
PMID:39354376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11443670/
Abstract

BACKGROUND

Children with chronic kidney disease (CKD) are at high risk of cardiovascular disease. Cardiovascular magnetic resonance (CMR) is the reference method for assessing cardiac remodeling. To our knowledge, no study has reported a comprehensive analysis of left ventricular(LV) cardiac remodeling using CMR in different stages of pediatric CKD. This prospective case-control study aimed to investigate cardiac remodeling in pediatric CKD, using CMR, and determine its relationship with risk factors.

METHOD

CMR was performed in 124 children with CKD and 50 controls. The cardiac remodeling parameters included left ventricular mass index (LVMI), LV remodeling index (LVRI), and LV wall thickness. Univariable and multivariable analyses were performed to assess the cardiac remodeling risk factors.

RESULTS

Cardiac remodeling was observed in 35.5% (44/124) of children with CKD. The LVMI, LVRI, and LV wall thickness were higher in advanced stages of CKD (P < 0.05). In the CKD stage 1-2 group, a lower in the estimated glomerular filtration rate was an independent determinant of impaired LVMI (β = -0.425, P = 0.019) and LVRI (β = -0.319, P = 0.044). A higher protein to creatinine ratio(PCR) was independently associated with impaired LVRI (β = 0.429, P = 0.022). In the CKD stage 3-5 group, higher in systolic blood pressure (SBP) (β = 0.464, P = 0.005) and PCR (β = 0.852, P = 0.031) were independent determinants of impaired LVMI. Additionally, higher SBP was positively correlated with impaired LVRI(r = 0.599, P < 0.001). There was a trend toward more abnormal cardiac remodeling in the CKD stage 3-5 group with hypertension than those without.

CONCLUSION

Cardiac remodeling is prevalent in children with CKD, from an early stage. kidney markers are independently associated with cardiac remodeling. Hypertension increases the risk of cardiac remodeling in CKD stages 3-5. Strict BP control may help reverse or prevent remodeling.

摘要

背景

慢性肾脏病(CKD)患儿患心血管疾病的风险很高。心血管磁共振成像(CMR)是评估心脏重塑的参考方法。据我们所知,尚无研究报道使用CMR对小儿CKD不同阶段的左心室(LV)心脏重塑进行全面分析。这项前瞻性病例对照研究旨在使用CMR调查小儿CKD的心脏重塑情况,并确定其与危险因素的关系。

方法

对124例CKD患儿和50例对照者进行CMR检查。心脏重塑参数包括左心室质量指数(LVMI)、左心室重塑指数(LVRI)和左心室壁厚度。进行单变量和多变量分析以评估心脏重塑的危险因素。

结果

在35.5%(44/124)的CKD患儿中观察到心脏重塑。CKD晚期患儿的LVMI、LVRI和左心室壁厚度更高(P<0.05)。在CKD 1-2期组中,估计肾小球滤过率降低是LVMI受损(β=-0.425,P=0.019)和LVRI受损(β=-0.319,P=0.044)的独立决定因素。较高的蛋白肌酐比值(PCR)与LVRI受损独立相关(β=0.429,P=0.022)。在CKD 3-5期组中,较高的收缩压(SBP)(β=0.464,P=0.005)和PCR(β=0.852,P=0.031)是LVMI受损的独立决定因素。此外,较高的SBP与LVRI受损呈正相关(r=0.599,P<0.001)。与无高血压的CKD 3-5期组相比,有高血压的CKD 3-5期组心脏重塑异常的趋势更明显。

结论

心脏重塑在CKD患儿中从早期就普遍存在。肾脏指标与心脏重塑独立相关。高血压增加了CKD 3-5期心脏重塑的风险。严格控制血压可能有助于逆转或预防重塑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc3/11443670/dc69d564b172/12872_2024_4179_Figd_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc3/11443670/9e9c242b93f4/12872_2024_4179_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc3/11443670/e85cfefd65e0/12872_2024_4179_Figb_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc3/11443670/ef4a546f1a1e/12872_2024_4179_Figc_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc3/11443670/dc69d564b172/12872_2024_4179_Figd_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc3/11443670/9e9c242b93f4/12872_2024_4179_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc3/11443670/e85cfefd65e0/12872_2024_4179_Figb_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc3/11443670/ef4a546f1a1e/12872_2024_4179_Figc_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cc3/11443670/dc69d564b172/12872_2024_4179_Figd_HTML.jpg

相似文献

1
Evaluation of cardiac remodeling in pediatric chronic kidney disease by cardiovascular magnetic resonance.通过心血管磁共振评估小儿慢性肾脏病中的心脏重塑
BMC Cardiovasc Disord. 2024 Oct 1;24(1):526. doi: 10.1186/s12872-024-04179-1.
2
A comprehensive characterization of myocardial and vascular phenotype in pediatric chronic kidney disease using cardiovascular magnetic resonance imaging.采用心血管磁共振成像技术对小儿慢性肾脏病的心肌和血管表型进行全面特征描述。
J Cardiovasc Magn Reson. 2018 Mar 29;20(1):24. doi: 10.1186/s12968-018-0444-0.
3
The additive effects of kidney dysfunction on left ventricular function and strain in type 2 diabetes mellitus patients verified by cardiac magnetic resonance imaging.心脏磁共振成像证实肾功能障碍对 2 型糖尿病患者左心室功能和应变的叠加效应。
Cardiovasc Diabetol. 2021 Jan 7;20(1):11. doi: 10.1186/s12933-020-01203-4.
4
Ambulatory systolic blood pressure and obesity are independently associated with left ventricular hypertrophic remodeling in children.动态收缩压和肥胖与儿童左心室肥厚重塑独立相关。
J Cardiovasc Magn Reson. 2017 Nov 9;19(1):86. doi: 10.1186/s12968-017-0401-3.
5
Early reverse remodeling of left heart morphology and function evaluated by cardiac magnetic resonance in hypertrophic obstructive cardiomyopathy after transapical beating-heart septal myectomy.经心尖跳动心脏室间隔心肌切除术治疗肥厚型梗阻性心肌病患者左心形态和功能的早期逆向重构:心脏磁共振评估。
J Cardiovasc Magn Reson. 2023 Nov 27;25(1):70. doi: 10.1186/s12968-023-00987-0.
6
Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study.韩国慢性肾脏病儿童的左心室舒张功能障碍:来自 KNOW-Ped CKD 研究的数据。
BMC Nephrol. 2020 Dec 9;21(1):533. doi: 10.1186/s12882-020-02152-6.
7
Impaired Myocardial Oxygenation Response to Stress in Patients With Chronic Kidney Disease.慢性肾脏病患者心肌氧合对应激的反应受损。
J Am Heart Assoc. 2015 Aug 10;4(8):e002249. doi: 10.1161/JAHA.115.002249.
8
Early impact of albuminuria on cardiac function in patients with chronic kidney disease: a prospective study.慢性肾脏病患者蛋白尿对心功能的早期影响:一项前瞻性研究。
Int J Cardiovasc Imaging. 2024 Apr;40(4):873-885. doi: 10.1007/s10554-024-03056-4. Epub 2024 Jan 19.
9
Impaired right ventricular contractile function in childhood obesity and its association with right and left ventricular changes: a cine DENSE cardiac magnetic resonance study.儿童肥胖症患者右心室收缩功能受损及其与左右心室变化的关联:一项磁共振心肌灌注成像心脏磁共振研究
J Cardiovasc Magn Reson. 2017 Jun 28;19(1):49. doi: 10.1186/s12968-017-0363-5.
10
FGF23 and Left Ventricular Hypertrophy in Children with CKD.成纤维细胞生长因子 23 与慢性肾脏病儿童的左心室肥厚
Clin J Am Soc Nephrol. 2018 Jan 6;13(1):45-52. doi: 10.2215/CJN.02110217. Epub 2017 Oct 12.

本文引用的文献

1
Evaluation of coronary microvascular dysfunction and risk factors in children and youth with Turner syndrome by magnetic resonance myocardial perfusion imaging.通过磁共振心肌灌注成像评估特纳综合征儿童和青少年的冠状动脉微血管功能障碍及危险因素。
Clin Endocrinol (Oxf). 2023 Apr;98(4):578-586. doi: 10.1111/cen.14866. Epub 2022 Dec 27.
2
Cardiac metabolic remodelling in chronic kidney disease.慢性肾脏病中的心脏代谢重塑
Nat Rev Nephrol. 2022 Aug;18(8):524-537. doi: 10.1038/s41581-022-00576-x. Epub 2022 May 30.
3
Cardiac biomarkers in pediatric CKD-a prospective follow-up study.
儿科 CKD 的心脏生物标志物:一项前瞻性随访研究。
Pediatr Nephrol. 2022 Dec;37(12):3165-3175. doi: 10.1007/s00467-022-05481-w. Epub 2022 Mar 16.
4
Global, segmental and layer specific analysis of myocardial involvement in Duchenne muscular dystrophy by cardiovascular magnetic resonance native T1 mapping.应用心血管磁共振 native T1 mapping 对杜氏肌营养不良症心肌受累的全局、节段和分层分析。
J Cardiovasc Magn Reson. 2021 Oct 14;23(1):110. doi: 10.1186/s12968-021-00802-8.
5
Cardiac biomarkers in chronic kidney disease are independently associated with myocardial edema and diffuse fibrosis by cardiovascular magnetic resonance.心血管磁共振显示,慢性肾脏病患者的心脏生物标志物与心肌水肿和弥漫性纤维化独立相关。
J Cardiovasc Magn Reson. 2021 Jun 7;23(1):71. doi: 10.1186/s12968-021-00762-z.
6
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.慢性肾脏病中的心血管疾病:病理生理学见解与治疗选择。
Circulation. 2021 Mar 16;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.
7
Uraemic Cardiomyopathy: A Review of Current Literature.尿毒症心肌病:当前文献综述
Clin Med Insights Cardiol. 2021 Feb 23;15:1179546821998347. doi: 10.1177/1179546821998347. eCollection 2021.
8
Cardiovascular disease in children with chronic kidney disease.儿童慢性肾脏病的心血管疾病。
Curr Opin Nephrol Hypertens. 2021 Mar 1;30(2):231-236. doi: 10.1097/MNH.0000000000000684.
9
Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.肥胖、性别与慢性肾脏病儿童心血管疾病风险:一项入组慢性肾脏病儿童研究(CKiD)的青少年纵向研究
Am J Kidney Dis. 2020 Aug;76(2):166-173. doi: 10.1053/j.ajkd.2020.01.011. Epub 2020 May 7.
10
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.